Brucella Omp25 activates the unfolded protein response to promote intracellular proliferation and inflammation.

阅读:3
作者:Yang Jin-Ke, Huang Shuang, Hou Yuan-Pan, Yuan Hui-Fei, Wang Yue, Li Mi, Cao Li-Bo, Xia Tian, Shu Hong-Bing, Wu Xin
Brucellosis is a widespread zoonotic disease caused by Brucella, a genus of facultative intracellular bacteria that infects livestock and humans. Brucella primarily replicates within the endoplasmic reticulum (ER) of host cells, where it establishes a specialized replicative niche. This ER localization disrupts ER structure and induces ER stress. The unfolded protein response (UPR) is a critical cellular pathway that maintains ER homeostasis by restoring protein-folding capacity and regulating stress responses. However, how Brucella manipulates host UPR pathways to promote its intracellular survival and pathogenesis remains poorly understood. Here, we identify the Brucella outer membrane protein Omp25 as a key factor in promoting its intracellular survival and proliferation by activating the host UPR. Omp25 directly binds to the ER chaperone binding-immunoglobulin protein, inducing the release and activation of the UPR sensors, PKR-like ER kinase, inositol-requiring enzyme 1 alpha, and activating transcription factor 6, thereby modulating ER homeostasis to favor bacterial replication. In addition, Omp25 enhances inflammatory cytokine expression via the binding-immunoglobulin protein-inositol-requiring enzyme 1 alpha-NF-κB signaling axis. The omp25-deleted strains (Δomp25) show impaired intracellular replication and reduced UPR activation and result in attenuated induction of inflammatory genes in infected cells compared with WT strains. In vivo, mice infected with an omp25 mutant strain exhibit lower bacterial burdens and milder tissue pathology compared with mice infected with the WT strain. These findings uncover a mechanism by which Omp25 facilitates Brucella intracellular proliferation through UPR modulation and highlight Omp25 as a potential target for therapeutic interventions and next-generation attenuated vaccines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。